Elevance Health I…
USUSDElevance Health Inc (LSE:0HG8) — Medical Specialities. Number of exchanges where the company shares trade: 2. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- elevancehealth.com
- Investor relations
- ir.elevancehealth.com/
- Sector
- Health Care · Medical Specialities
- Headquarters
- Indianapolis, United States
- CEO
- Gail Boudreaux
- Employees
- 96 129
- Founded
- 1940
- Shares outstanding
- Free float
- 216.37 M
- Market cap
- 85.17 B USD
- Insiders
- 0.19%
- Institutions
- 94.15%
- Industry (SIC)
- Hospital & Medical Service Plans
- Legal form
- R0BI
- ISIN
- US0367521038
- LEI
- 8MYN82XMYQH89CTMTH67
- P/E
- 15.6
- P/B
- 2.13
- Payout ratio
- 30.4%
- FCF
- 6.29 B USD
- Payout / FCF
- 24%
- Debt
- 31.0 B USD3.3 y of FCF
- Dividend streak
- 15 y
- Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
- NAV
Description
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Dividends
Elevance Health Inc (ELV) pays dividends quarterly. Per year (12 months up to and including the latest announced payment): 6.88 USD per share (payments: 4). That is about 1.56% of the current share price. The next ex-dividend date is 04.12.2026: 1.72 USD per share, paid on 18.12.2026. Uninterrupted dividend history: 15 years.
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-12-04 announced | 2026-12-18 | 1.7200 USD | 0.4/1.6 % | quarterly | US:ELV |
| 2026-09-10 | 2026-09-25 | 1.7200 USD | 0.4/1.7 % | quarterly | US:ELV |
| 2026-06-10 | 2026-06-25 | 1.7200 USD | 0.4/1.6 % | quarterly | US:ELV |
| 2026-03-10 | 2026-03-25 | 1.7200 USD | 0.6/2.4 % | quarterly | US:ELV |
| 2025-12-05 | 2025-12-19 | 1.7100 USD | 0.5/2.1 % | quarterly | US:ELV |
| 2025-09-10 | 2025-09-25 | 1.7100 USD | 0.5/2.1 % | quarterly | US:ELV |
| 2025-06-10 | 2025-06-25 | 1.7100 USD | 0.4/1.7 % | quarterly | US:ELV |
| 2025-03-10 | 2025-03-25 | 1.7100 USD | 0.4/1.6 % | quarterly | US:ELV |
| 2024-12-05 | 2024-12-20 | 1.6300 USD | 0.4/1.6 % | quarterly | US:ELV |
| 2024-09-10 | 2024-09-25 | 1.6300 USD | 0.4/1.4 % | quarterly | US:ELV |
| 2024-06-10 | 2024-06-25 | 1.6300 USD | 0.4/1.4 % | quarterly | US:ELV |
| 2024-03-07 | 2024-03-22 | 1.6300 USD | 0.4/1.4 % | quarterly | US:ELV |
| 2023-12-05 | 2023-12-21 | 1.4800 USD | 0.3/1.3 % | quarterly | US:ELV |
| 2023-09-07 | 2023-09-22 | 1.4800 USD | 0.3/1.3 % | quarterly | US:ELV |
| 2023-06-08 | 2023-06-23 | 1.4800 USD | 0.3/1.3 % | quarterly | US:ELV |
| 2023-03-09 | 2023-03-24 | 1.4800 USD | 0.3/1.2 % | quarterly | US:ELV |
| 2022-12-02 | 2022-12-21 | 1.2800 USD | 0.3/1.2 % | quarterly | US:ELV |
| 2022-09-08 | 2022-09-23 | 1.2800 USD | 0.3/1.1 % | quarterly | US:ELV |
| 2022-06-09 | 2022-06-24 | 1.2800 USD | 0.3/0.8 % | quarterly | US:ELV |
| 2022-03-09 | 2022-03-25 | 1.2800 USD | 0.3/0.5 % | quarterly | US:ELV |
| 2021-12-02 | 2021-12-21 | 1.1300 USD | 0.3/0.3 % | quarterly | US:ELV |
News this week
Press releases from the company's investor website, updated daily. Links lead to the company's website. Headlines are in the original language, as on the company website.
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| Blackrock Inc. | 8.76% | 18.99 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.48% | 14.06 M | 2026-06-30 |
| State Street Corporation | 4.81% | 10.43 M | 2026-06-30 |
| Wellington Management Gr… | 4.25% | 9.21 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.05% | 6.61 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.87% | 6.21 M | 2026-06-30 |
| Sanders Capital, LLC | 2.69% | 5.83 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.49% | 5.39 M | 2026-06-30 |
| Geode Capital Management… | 2.38% | 5.17 M | 2026-06-30 |
| Harris Associates L.P. | 2.27% | 4.92 M | 2026-06-30 |
| Artisan Partners Limited… | 2.11% | 4.58 M | 2026-06-30 |
| Invesco Ltd. | 1.95% | 4.23 M | 2026-06-30 |
| VANGUARD WINDSOR FUNDS-V… | 1.4% | 3.04 M | 2026-07-31 |
| iShares Trust-iShares Co… | 1.33% | 2.89 M | 2026-08-31 |
| First Eagle Funds-First… | 1.31% | 2.84 M | 2026-07-31 |
| Fidelity Concord Street… | 1.29% | 2.81 M | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.23% | 2.66 M | 2026-08-31 |
| VANGUARD FENWAY FUNDS-Va… | 0.94% | 2.05 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.93% | 2.02 M | 2026-06-30 |
| VANGUARD SPECIALIZED FUN… | 0.86% | 1.86 M | 2026-07-31 |
| BOUDREAUX GAIL A KOZIARA… | ≈0.08% | 172 036 | 2026-07-17 |
| BOUDREAUX GAIL KOZIARA (… | ≈0.08% | 169 311 | 2026-03-02 |
| NORWOOD FELICIA F. (Offi… | ≈0.02% | 38 838 | 2026-03-02 |
| KAYE MARK (Chief Financi… | ≈0.01% | 32 037 | 2026-03-02 |
| HAYTAIAN PETER D (Office… | ≈0.01% | 27 222 | 2026-03-02 |
| LAVU RATNAKAR (Chief Tec… | ≈0.01% | 16 149 | 2026-03-02 |
| HAY LEWIS III (Director) | ≈0.01% | 12 070 | 2026-05-13 |
| KENDRICK CHARLES MORGAN… | ≈0.01% | 11 791 | 2026-03-06 |
| PERU RAMIRO G (Director) | ≈0.01% | 10 908 | 2026-07-17 |
| DIXON ROBERT L JR (Direc… | ≈0% | 10 734 | 2026-06-11 |
